Acute lymphoblastic leukemia laboratory findings: Difference between revisions
Jump to navigation
Jump to search
Kamal Akbar (talk | contribs) |
Kamal Akbar (talk | contribs) |
||
| Line 15: | Line 15: | ||
* A chemistry panel may also demonstrate altered concentrations of the following:<ref name=ALL>{{cite web | title = National Cancer Institute| url =http://www.cancer.gov/types/leukemia/hp/adult-all-treatment-pdq#link/_26_toc }}</ref> | * A chemistry panel may also demonstrate altered concentrations of the following:<ref name=ALL>{{cite web | title = National Cancer Institute| url =http://www.cancer.gov/types/leukemia/hp/adult-all-treatment-pdq#link/_26_toc }}</ref> | ||
**[[Uric acid]] | **[[Uric acid]] | ||
**[[Creatinine]] | **[[Creatinine]]<ref name="pmid23960347">{{cite journal| author=Bhatia NG, Sneha LM, Selvan SM, Scott JJ| title=Acute renal failure as an initial manifestation of acute lymphoblastic leukemia. | journal=Indian J Nephrol | year= 2013 | volume= 23 | issue= 4 | pages= 292-3 | pmid=23960347 | doi=10.4103/0971-4065.114472 | pmc=3741975 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23960347 }} </ref> | ||
**[[Blood urea nitrogen]]<ref name="pmid25561892">{{cite journal| author=Rasool M, Farooq S, Malik A, Shaukat A, Manan A, Asif M et al.| title=Assessment of circulating biochemical markers and antioxidative status in acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) patients. | journal=Saudi J Biol Sci | year= 2015 | volume= 22 | issue= 1 | pages= 106-11 | pmid=25561892 | doi=10.1016/j.sjbs.2014.09.002 | pmc=4281600 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25561892 }} </ref> | **[[Blood urea nitrogen]]<ref name="pmid25561892">{{cite journal| author=Rasool M, Farooq S, Malik A, Shaukat A, Manan A, Asif M et al.| title=Assessment of circulating biochemical markers and antioxidative status in acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) patients. | journal=Saudi J Biol Sci | year= 2015 | volume= 22 | issue= 1 | pages= 106-11 | pmid=25561892 | doi=10.1016/j.sjbs.2014.09.002 | pmc=4281600 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25561892 }} </ref> | ||
**[[Potassium]]<ref name="pmid20838546">{{cite journal| author=Ali A, Aziz SA, Khan A, Gelani S| title=Persistent hypokalemia in an acute lymphoblastic leukemia patient. | journal=Indian J Med Paediatr Oncol | year= 2009 | volume= 30 | issue= 3 | pages= 103-4 | pmid=20838546 | doi=10.4103/0971-5851.64255 | pmc=2930287 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20838546 }} </ref> | **[[Potassium]]<ref name="pmid20838546">{{cite journal| author=Ali A, Aziz SA, Khan A, Gelani S| title=Persistent hypokalemia in an acute lymphoblastic leukemia patient. | journal=Indian J Med Paediatr Oncol | year= 2009 | volume= 30 | issue= 3 | pages= 103-4 | pmid=20838546 | doi=10.4103/0971-5851.64255 | pmc=2930287 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20838546 }} </ref> | ||
Revision as of 20:04, 30 January 2019
|
Acute lymphoblastic leukemia Microchapters |
|
Differentiating Acute lymphoblastic leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Acute lymphoblastic leukemia laboratory findings On the Web |
|
American Roentgen Ray Society Images of Acute lymphoblastic leukemia laboratory findings |
|
Acute lymphoblastic leukemia laboratory findings in the news |
|
Directions to Hospitals Treating Acute lymphoblastic leukemia |
|
Risk calculators and risk factors for Acute lymphoblastic leukemia laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [4] Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [5] Carlos A Lopez, M.D. [6]
Ovierview
Laboratory findings consistent with the diagnosis of acute lymphoblastic leukemia include eosinophilia, lymphocytosis, red cell production reduced, thrombocytopenia. Chemistry panels with altered levels of uric acid, creatinine, blood urea nitrogen, potassium, phosphate, calcium, bilirubin, hepatic transaminases and ferritin.
Laboratory Findings
Laboratory findings consistent with the diagnosis of acute lymphoblastic leukemia include:[1]
- Anemia[2]
- Lymphocytosis
- Thrombocytopenia[3]
- Eosinophilia[4]
- A chemistry panel may also demonstrate altered concentrations of the following:[5]
- A spinal tap is often required to evaluate for central nervous system involvement.
![[1]](https://commons.wikimedia.org/wiki/Category:Acute_lymphoblastic_leukemia#/media/File:ALL-L1.jpg){kind=link}
![[2]](https://commons.wikimedia.org/wiki/File:ALL-KM-2.jpg){kind=link}
![[3]](https://commons.wikimedia.org/wiki/File:ALL-KM-3.jpg){kind=link}
References
- ↑ Chiaretti S, Zini G, Bassan R (2014). "Diagnosis and subclassification of acute lymphoblastic leukemia". Mediterr J Hematol Infect Dis. 6 (1): e2014073. doi:10.4084/MJHID.2014.073. PMC 4235437. PMID 25408859.
- ↑ Steele M, Narendran A (2012). "Mechanisms of defective erythropoiesis and anemia in pediatric acute lymphoblastic leukemia (ALL)". Ann Hematol. 91 (10): 1513–8. doi:10.1007/s00277-012-1475-5. PMID 22543829.
- ↑ Dubansky AS, Boyett JM, Falletta J, Mahoney DH, Land VJ, Pullen J; et al. (1989). "Isolated thrombocytopenia in children with acute lymphoblastic leukemia: a rare event in a Pediatric Oncology Group Study". Pediatrics. 84 (6): 1068–71. PMID 2587136.
- ↑ Rezamand A, Ghorashi Z, Ghorashi S, Nezami N (2013). "Eosinophilic presentation of acute lymphoblastic leukemia". Am J Case Rep. 14: 143–6. doi:10.12659/AJCR.883905. PMC 3715333. PMID 23869247.
- ↑ "National Cancer Institute".
- ↑ Bhatia NG, Sneha LM, Selvan SM, Scott JJ (2013). "Acute renal failure as an initial manifestation of acute lymphoblastic leukemia". Indian J Nephrol. 23 (4): 292–3. doi:10.4103/0971-4065.114472. PMC 3741975. PMID 23960347.
- ↑ 7.0 7.1 7.2 7.3 Rasool M, Farooq S, Malik A, Shaukat A, Manan A, Asif M; et al. (2015). "Assessment of circulating biochemical markers and antioxidative status in acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) patients". Saudi J Biol Sci. 22 (1): 106–11. doi:10.1016/j.sjbs.2014.09.002. PMC 4281600. PMID 25561892.
- ↑ Ali A, Aziz SA, Khan A, Gelani S (2009). "Persistent hypokalemia in an acute lymphoblastic leukemia patient". Indian J Med Paediatr Oncol. 30 (3): 103–4. doi:10.4103/0971-5851.64255. PMC 2930287. PMID 20838546.
- ↑ Heincelman M, Karakala N, Rockey DC (2016). "Acute Lymphoblastic Leukemia in a Young Adult Presenting as Hepatitis and Acute Kidney Injury". J Investig Med High Impact Case Rep. 4 (3): 2324709616665866. doi:10.1177/2324709616665866. PMC 5036134. PMID 27722178.